These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 28800460)
1. Synthesis and biological evaluation of 4-biphenylamino-5-halo-2(5H)-furanones as potential anticancer agents. Wu YC; Luo SH; Mei WJ; Cao L; Wu HQ; Wang ZY Eur J Med Chem; 2017 Oct; 139():84-94. PubMed ID: 28800460 [TBL] [Abstract][Full Text] [Related]
2. Flavokawain derivative FLS induced G2/M arrest and apoptosis on breast cancer MCF-7 cell line. Ali NM; Akhtar MN; Ky H; Lim KL; Abu N; Zareen S; Ho WY; Alan-Ong HK; Tan SW; Alitheen NB; Ismail JB; Yeap SK; Kamarul T Drug Des Devel Ther; 2016; 10():1897-907. PubMed ID: 27358555 [TBL] [Abstract][Full Text] [Related]
3. Bis-2(5H)-furanone derivatives as new anticancer agents: Design, synthesis, biological evaluation, and mechanism studies. Wu YC; Cao L; Mei WJ; Wu HQ; Luo SH; Zhan HY; Wang ZY Chem Biol Drug Des; 2018 Jul; 92(1):1232-1240. PubMed ID: 29469985 [TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer. Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of new sarsasapogenin derivatives with cytotoxicity and apoptosis-inducing activities in human breast cancer MCF-7 cells. Wang W; Wang D; Wang Z; Yao G; Li X; Gao P; Li L; Zhang Y; Wang S; Song S Eur J Med Chem; 2017 Feb; 127():62-71. PubMed ID: 28038327 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitumor activities evaluation of m-(4-morpholinoquinazolin-2-yl)benzamides in vitro and in vivo. Wang XM; Xin MH; Xu J; Kang BR; Li Y; Lu SM; Zhang SQ Eur J Med Chem; 2015; 96():382-95. PubMed ID: 25911625 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents. Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives. Gorle S; Maddila S; Maddila SN; Naicker K; Singh M; Singh P; Jonnalagadda SB Anticancer Agents Med Chem; 2017; 17(3):464-470. PubMed ID: 27357544 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents. Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of a New Series of Arylidene Indanones as Potential Anticancer Agents. Özdemir A; Gökbulut S; Sever B; Çiftçi GA; Altıntop MD Anticancer Agents Med Chem; 2018; 18(10):1394-1404. PubMed ID: 29210665 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents. Ayati A; Esmaeili R; Moghimi S; Oghabi Bakhshaiesh T; Eslami-S Z; Majidzadeh-A K; Safavi M; Emami S; Foroumadi A Eur J Med Chem; 2018 Feb; 145():404-412. PubMed ID: 29335206 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors. Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones. Eldehna WM; Ibrahim HS; Abdel-Aziz HA; Farrag NN; Youssef MM Eur J Med Chem; 2015 Jan; 89():549-60. PubMed ID: 25462265 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents. Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and evaluation of calix[4]arene-based carbonyl amide derivatives with antitumor activities. An L; Wang C; Zheng YG; Liu JD; Huang TH Eur J Med Chem; 2021 Jan; 210():112984. PubMed ID: 33183867 [TBL] [Abstract][Full Text] [Related]
16. Synthesis, biological evaluation and molecular modeling studies of some novel thiazolidinediones with triazole ring. Chinthala Y; Kumar Domatti A; Sarfaraz A; Singh SP; Kumar Arigari N; Gupta N; Satya SK; Kotesh Kumar J; Khan F; Tiwari AK; Paramjit G Eur J Med Chem; 2013; 70():308-14. PubMed ID: 24177357 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents. Huang G; Zhao HR; Meng QQ; Zhang QJ; Dong JY; Zhu BQ; Li SS Eur J Med Chem; 2018 Jan; 143():166-181. PubMed ID: 29174813 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of selenazolopyridine derivatives with capability to induce apoptosis in human breast carcinoma MCF-7 cells through scavenge of intracellular ROS. Zhou M; Ji S; Wu Z; Li Y; Zheng W; Zhou H; Chen T Eur J Med Chem; 2015; 96():92-7. PubMed ID: 25874334 [TBL] [Abstract][Full Text] [Related]
19. The Effects of 1,3,5-trisubstituted Indole Derivatives on Cell Growth, Apoptosis and MMP-2/9 mRNA Expression of MCF-7 Human Breast Cancer Cells. Bakar F; Kilic-Kurt Z; Caglayan MG; Olgen S Anticancer Agents Med Chem; 2017; 17(5):762-767. PubMed ID: 27491936 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors. Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]